Risk stratification in ACS F.Shakib .cardiologigst

Slides:



Advertisements
Similar presentations
Patient Oriented Therapy Non STE ACS
Advertisements

Invasive Ticagrelor compared with clopidogrel in patients with acute coronary syndromes – the PLATelet Inhibition and patient Outcomes trial Outcomes in.
Approach to The Low Risk Chest Pain Patient John P Erwin, III, MD, FACC, FAHA Associate Professor of Medicine Scott and White Heart and Vascular Institute.
Risk stratification and medical management of NSTE-ACS (UA/NSTEMI )
ACUTE CORONARY SYNDROME Jarrod D. Frizzell, MD, MS Fellow, Cardiovascular Medicine July 10, 2014.
ACS guidelines Pre-program To understand the ACS guidelines it is necessary to know mortality risk if you do nothing and bleeding risk for different kinds.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
Myocardial Infarction
Amr Hassan Mostafa, MD, FSCAI A. Professor of Cardiology Cairo University Cairo, Egypt Egypt Combat MI, March 24-25, Cairo Sheraton.
ACUTE CORONARY SYNDROME (ACS). ACS Pathophysiology is that of a ruptured or eroded atheromatous plaque. Pathophysiology is that of a ruptured or eroded.
Quality Improvement Initiatives. National Service Framework for Coronary Heart Disease-UK Cooperative Cardiovascular Project (CCP)-USA National Registry.
ACUTE CORONARY SYNDROME Jarrod D. Frizzell, MD, MS Fellow, Cardiovascular Medicine July 9, 2015.
ACUTE CORONARY SYNDORME Mostafa alshamiri January 2013.
ACUTE CORONARY SYNDROMES Part I. Definition Acute coronary syndrome (ACS) describes a spectrum of clinical conditions ranging from ST segment elevation.
SPACE The Saudi Project for Assessment of Coronary Events A registry database of patients with ACS. A registry database of patients with ACS. Provides.
Acute Coronary Syndrome David Aymond, MD. ACS Definition: Myocardial ischemia typically due to atherosclerotic plaque rupture  Coronary thrombosis ACS.
Acute Coronary Syndromes in West Hertfordshire Masood Khan.
Coronary Heart Disease (CHD) László Tornóci Inst. Pathophysiology Semmelweis University.
Implementation of a Sensitive Troponin I Assay and Risk of Recurrent Myocardial Infarction and Death in Patients With Suspected Acute Coronary Syndrome.
Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: The thrombolysis in myocardial infarction risk score.
Date of download: 5/28/2016 From: Optimal Timing of Coronary Invasive Strategy in Non–ST-Segment Elevation Acute Coronary Syndromes: A Systematic Review.
Chest Pain in the Emergency Department Junior Teaching C. Brown August 2015.
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Nuisance Bleeding With Prolonged Dual Antiplatelet.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2014 AHA/ACC Guideline for the Management of Patients.
Acute Coronary Syndrome
Objectives Review chest pain Define ACS
Risk Stratification of Chest Pain: Best Practices
Arch Intern Med. 2007;167(1): doi: /archinte Figure Legend:
Figure 1 Patient flow chart.
Ischemic Heart Disease
Copyright © 2005 American Medical Association. All rights reserved.
Ischaemic Heart Disease Acute Coronary Syndrome
Copyright © 2009 American Medical Association. All rights reserved.
Circ Cardiovasc Interv
CHD-related catheterization
Discharge Heart Rate and Mortality after Acute Myocardial Infarction
R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R
Figure 3 Ischaemic outcomes in the ST-segment elevation myocardial
Section A: Introduction
European Heart Association Journal 2007 April
Recent Temporal Trends in the Presentation, Management, and Outcome of Women Hospitalized with Acute Coronary Syndromes  Avi Sabbag, MD, Shlomi Matetzky,
Figure 2 Ischaemic and bleeding outcomes in the major clinical trials
Date: Presenter: Ryan Chen
Press Conference Title
Cost-Effectiveness of Introducing Point-of-Care Test for Detection of Level of Glycogen Phosphorylase in Early Diagnostic Algorithm of Acute Coronary.
Kay Lee Park, MD, Robert J. Goldberg, PhD, Frederick A
Leonardo P. de Carvalho et al. BTS 2018;3:
American College of Cardiology Presented by Dr. Michel R. Le May
Attributable Cost and Length of Stay for Patients with Enoxaparin-Associated Bleeding  Surasak Saokaew, PharmD, Narinee Khaisombat, MSc, Nathorn Chaiyakunapruk,
Risk Stratification in Non-ST-segment Elevation Acute Coronary Syndromes: Troponin Alone Is not Enough  Philippe Gabriel Steg, Gordon FitzGerald, Keith.
Figure 2 Absolute difference in seasonal peak
Figure 4 Observational studies on multiple treatment strategies
Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris  Toshihiro Fukui,
Flow chart of the study population according to thienopyridines used in the FAST-MI registry in patients with STEMI and NSTEMI. FAST-MI, French Registry.
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic.
High Sensitivity Troponin (hsTnT) : Result Interpretation Matrix*
OHSU - BDMS Heart CoE ACS Program
Acute coronary syndromes: diagnosis
Urban–Rural Comparisons in Hospital Admission, Treatments, and Outcomes for ST-Segment–Elevation Myocardial Infarction in China From 2001 to 2011 A Retrospective.
MRRs and EMRRs for women with ACS
A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.
Javier Escaned et al. JCIN 2018;11:
Propensity score-matching
Use of evidence-based cardiac medications before, during and after hospitalisation for the index event in (A) overall ACS population and (B) patients with.
R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R
Performance of the Manchester Acute Coronary Syndromes decision rule in the validation study. Performance of the Manchester Acute Coronary Syndromes decision.
Prevalence of acute myocardial infarction (AMI) or other cardiovascular events (CVEs) according to a) Pneumonia Severity Index (PSI) risk classes and b)
Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.
Study flow chart and diagnosis at discharge from ED
Presentation transcript:

Risk stratification in ACS F.Shakib .cardiologigst 1.3 milion patients have UA and NSTEMI Less than 1 milion patients suffer from STEMI

Risk stratification in ACS F.Shakib .cardiologigst UA Definition At least one of three features; 1.At rest pain lasting more than 20 minute 2. Severe and new onset 3. Cresendo pattern

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst Scoring method TIMI(thrombolysis in myocardial infarction ) GRACE (global registry of acute coronary event) AHA/ACC

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Risk stratification in ACS F.Shakib .cardiologigst

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.